Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy |
| |
| Authors: | C M Tran A S Moore A E Frimberger |
| |
| Affiliation: | 1. Animal Referral Hospital, Sydney, New South Wales, Australia;2. Veterinary Oncology Consultants, Wauchope, New South Wales, Australia |
| |
| Abstract: | This retrospective study identified prognostic factors associated with survival; and compared survival data in 94 canine mammary carcinoma (MCA) dogs treated with surgery (n = 58), or surgery and adjunct chemotherapy (n = 36), and a subset of dogs with poor prognostic factors. On multivariate analysis independent predictors of median survival time (MST) were clinical stage, lymphatic invasion (LI; present 179 days; none 1098 days), ulceration (present 118 days; none 443 days) and surgical margins (incomplete 70 days; complete 872 days). Complete surgical margins were associated with MST in dogs with stages 1–3 MCA (incomplete 68 days; complete 1098 days) and dogs with LI (incomplete 70 days; complete 347 days). There was no statistically significant improvement in MST in dogs with advanced disease (stage 4 or LI) treated with adjunctive chemotherapy (chemotherapy 228 days; none 194 days); although five dogs with complete surgical margins that received mitoxantrone and carboplatin had a mean survival of 1139 days. |
| |
| Keywords: | cancer canine mammary cancer mammary tumour oncology small animal |
|
|
